Evidence of reactivation of hepatitis B virus in patients receiving chemotherapy for malignancies

被引：0
|
作者：
Ikeda, Masafumi [1 ]
Takahashi, Hideaki [1 ]
Hashimoto, Yusuke [1 ]
Ohno, Izumi [1 ]
Mitsunaga, Shuichi [1 ]
Umemoto, Kumiko [1 ]
Watanabe, Kazuo [1 ]
Okusaka, Takuji [2 ]
机构：
[1] Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, Japan
[2] Natl Canc Ctr, Dept Hepatobiliary & Pancreat Oncol, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SY-2-1
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Hepatitis B Virus Reactivation in Patients Receiving Bruton Tyrosine Kinase Inhibitors
    Chiu, Chia-Yu
    Ahmed, Sairah
    Thomas, Sheeba K.
    Wang, Lan Sun
    Mustafayev, Khalis
    Fayad, Luis E.
    Wierda, William G.
    Khawaja, Fareed
    Torres, Harrys A.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 (08): : 610 - 615
  • [42] HEPATITIS B VIRUS REACTIVATION IN CANCER PATIENTS RECEIVING JANUS KINASE INHIBITORS
    Mustafayev, Khalis
    Short, Nicholas
    Chien, Kelly
    Daver, Naval
    Khawaja, Fareed
    Torres, Harrys
    HEPATOLOGY, 2024, 80 : S271 - S271
  • [43] Reactivation of hepatitis B virus infection in patients with rheumatoid arthritis receiving tofacitinib
    Wang, Sz-Tsan
    Tseng, Chih-Wei
    Hsu, Chia-Wen
    Tung, Chien-Hsueh
    Huang, Kuang-Yung
    Lu, Ming-Chi
    Lai, Ning-Sheng
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2021, 24 (11) : 1362 - 1369
  • [44] Reactivation of Hepatitis B Virus in Autoimmune Disease Patients Receiving Immunosuppressive Agents
    Kobayashi, Daisuke
    Ito, Satoshi
    Unno, Megumi
    Narita, Ichiei
    Murasawa, Akira
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S885 - S886
  • [45] Strategies to Prevent Hepatitis B Virus Reactivation in Patients Receiving Immunosuppressive Therapy
    Hsu, Chiun
    Wei, Shu-Chen
    Cheng, Ann-Lii
    Chen, Pei-Jer
    HEPATOLOGY, 2009, 50 (02) : 654 - 655
  • [46] HEPATITIS B REACTIVATION AND USE OF PRE- EMPTIVE HEPATITIS B TREATMENT IN CANCER PATIENTS RECEIVING CHEMOTHERAPY
    Kwak, Ye Eun
    Lim, Joseph K.
    GASTROENTEROLOGY, 2017, 152 (05) : S1052 - S1052
  • [47] Hepatitis B Virus Reactivation after Receiving Cancer Chemotherapy under Administration of Leuprorelin Acetate
    Yamauchi, Ryo
    Takeyama, Yasuaki
    Takata, Kazuhide
    Fukunaga, Atsushi
    Sakurai, Kunitoshi
    Tanaka, Takashi
    Fukuda, Hiromi
    Fukuda, Sho
    Kunimoto, Hideo
    Umeda, Kaoru
    Morihara, Daisuke
    Yokoyama, Keiji
    Irie, Makoto
    Shakado, Satoshi
    Sakisaka, Shotaro
    Hirai, Fumihito
    INTERNAL MEDICINE, 2020, 59 (09) : 1163 - 1166
  • [48] Prevention of hepatitis B reactivation with lamivudine in hepatitis B virus carriers with hematologic malignancies treated with chemotherapy - A prospective case series
    Vassiliadis, T
    Garipidou, V
    Tziomalos, K
    Perifanis, V
    Giouleme, O
    Vakalopoulou, S
    AMERICAN JOURNAL OF HEMATOLOGY, 2005, 80 (03) : 197 - 203
  • [49] Evaluating the risk of hepatitis B reactivation in patients with haematological malignancies: is the serum hepatitis B virus profile reliable?
    Ferraro, Donatella
    Pizzillo, Paola
    Di Marco, Vito
    Vultaggio, Anna
    Iannitto, Emilio
    Venezia, Giovanna
    Craxi, Antonio
    Di Stefano, Rosa
    LIVER INTERNATIONAL, 2009, 29 (08) : 1171 - 1177
  • [50] Frequency of hepatitis B virus mutant in asymptomatic hepatitis B virus carriers receiving prophylactic lamivudine during chemotherapy for hematologic malignancies
    Pelizzari, AM
    Motta, M
    Cariani, E
    Turconi, P
    Borlenghi, E
    Rossi, G
    HEMATOLOGY JOURNAL, 2004, 5 (04) : 325 - 328
12345